ConductScience.org, home

Gene · 369

Papers2,279

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

981 to 1,000 of 2,279

Download this page as JSON
TitleJournalYearPMIDFound bySource
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors.J Clin Oncol202032182156PubTator, text miningPubMed
Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies.Mol Cancer Ther202032127467PubTator, text miningPubMed
Array-based Western-blotting reveals spatial differences in hepatic signaling and metabolism following CAR activation.Arch Toxicol202032123963PubTator, text miningPubMed
Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer.Cancers (Basel)202032120793PubTator, text miningPubMed
ERK/MAPK signalling pathway and tumorigenesis.Exp Ther Med202032104259PubTator, text miningPubMed
Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors.Cancer Cell Int202032099531PubTator, text miningPubMed
Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer.Prostate Cancer Prostatic Dis202032094488PubTator, text miningPubMed
Current Advances in the Treatment of BRAF-Mutant Melanoma.Cancers (Basel)202032092958PubTator, text miningPubMed
Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer.Int J Mol Sci202032069845PubTator, text miningPubMed
BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors.BMC Cancer202032066410PubTator, text miningPubMed
GHR gene transcript heterogeneity may explain phenotypic variability in GHR pseudoexon (6Ψ) patients.Endocr Connect202032061156PubTator, text miningPubMed
Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion.Ther Adv Med Oncol202032047535PubTator, text miningPubMed
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity.Int J Mol Sci202032046099PubTator, text miningPubMed
A Novel Pectic Polysaccharide of Jujube Pomace: Structural Analysis and Intracellular Antioxidant Activities.Antioxidants (Basel)202032024245PubTator, text miningPubMed
Congenital heart defects in Noonan syndrome: Diagnosis, management, and treatment.Am J Med Genet C Semin Med Genet202032022400PubTator, text miningPubMed
Structure-Mediated RNA Decay by UPF1 and G3BP1.Mol Cell202032017897PubTator, text miningPubMed
The ubiquitin system: orchestrating cellular signals in non-small-cell lung cancer.Cell Mol Biol Lett202031988639PubTator, text miningPubMed
Extensive rewiring of the EGFR network in colorectal cancer cells expressing transforming levels of KRASG13D.Nat Commun202031980649PubTator, text miningPubMed
The ubiquitin ligase HERC1 regulates cell migration via RAF-dependent regulation of MKK3/p38 signaling.Sci Rep202031965002PubTator, text miningPubMed
The road to ERK activation: Do neurons take alternate routes?Cell Signal202031945453PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/369/papers?page=50